146 related articles for article (PubMed ID: 17622670)
1. Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression.
Kumar S; Ponnazhagan S
FASEB J; 2007 Dec; 21(14):3917-27. PubMed ID: 17622670
[TBL] [Abstract][Full Text] [Related]
2. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells.
Lien CY; Chih-Yuan Ho K; Lee OK; Blunn GW; Su Y
J Bone Miner Res; 2009 May; 24(5):837-48. PubMed ID: 19113920
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.
Song H; Chang W; Lim S; Seo HS; Shim CY; Park S; Yoo KJ; Kim BS; Min BH; Lee H; Jang Y; Chung N; Hwang KC
Stem Cells; 2007 Jun; 25(6):1431-8. PubMed ID: 17347495
[TBL] [Abstract][Full Text] [Related]
5. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.
Liang X; Su YP; Kong PY; Zeng DF; Chen XH; Peng XG; Zou ZM; Xu H
Int J Radiat Biol; 2010 Mar; 86(3):230-7. PubMed ID: 20201651
[TBL] [Abstract][Full Text] [Related]
6. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
[TBL] [Abstract][Full Text] [Related]
7. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy.
Gazit D; Turgeman G; Kelley P; Wang E; Jalenak M; Zilberman Y; Moutsatsos I
J Gene Med; 1999; 1(2):121-33. PubMed ID: 10738576
[TBL] [Abstract][Full Text] [Related]
8. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells.
Noël D; Gazit D; Bouquet C; Apparailly F; Bony C; Plence P; Millet V; Turgeman G; Perricaudet M; Sany J; Jorgensen C
Stem Cells; 2004; 22(1):74-85. PubMed ID: 14688393
[TBL] [Abstract][Full Text] [Related]
9. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
[TBL] [Abstract][Full Text] [Related]
13. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier.
Kasten P; Vogel J; Luginbühl R; Niemeyer P; Tonak M; Lorenz H; Helbig L; Weiss S; Fellenberg J; Leo A; Simank HG; Richter W
Biomaterials; 2005 Oct; 26(29):5879-89. PubMed ID: 15913762
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
15. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
[TBL] [Abstract][Full Text] [Related]
16. Migratory strategies of normal and malignant stem cells.
Hess DA; Allan AL
Methods Mol Biol; 2011; 750():25-44. PubMed ID: 21618081
[TBL] [Abstract][Full Text] [Related]
17. A novel strategy incorporated the power of mesenchymal stem cells to allografts for segmental bone tissue engineering.
Zou XH; Cai HX; Yin Z; Chen X; Jiang YZ; Hu H; Ouyang HW
Cell Transplant; 2009; 18(4):433-41. PubMed ID: 19622230
[TBL] [Abstract][Full Text] [Related]
18. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model.
Tasso R; Fais F; Reverberi D; Tortelli F; Cancedda R
Biomaterials; 2010 Mar; 31(8):2121-9. PubMed ID: 20004968
[TBL] [Abstract][Full Text] [Related]
19. Skeletal phenotype of growing transgenic mice that express a function-perturbing form of beta1 integrin in osteoblasts.
Globus RK; Amblard D; Nishimura Y; Iwaniec UT; Kim JB; Almeida EA; Damsky CD; Wronski TJ; van der Meulen MC
Calcif Tissue Int; 2005 Jan; 76(1):39-49. PubMed ID: 15477996
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of genetically modified mesenchymal stem cells.
Kumar S; Chanda D; Ponnazhagan S
Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
